LOGIN  |  REGISTER
Astria Therapeutics

Recent Insider Transactions - Collegium Pharmaceutical (NASDAQ: COLL)

Follow NASDAQ:COLL Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ COLL Collegium Pharmaceutical
Dreyer Scott / officer: EVP & Chief Commercial Officer
08/18/2025
Buy
$21.34
16,389
$350K
120,002
NASDAQ COLL Collegium Pharmaceutical
Dreyer Scott / officer: EVP & Chief Commercial Officer
08/18/2025
Sell
$38.21
16,389
$626K
103,613
NASDAQ COLL Collegium Pharmaceutical
Dreyer Scott / officer: EVP & Chief Commercial Officer
08/18/2025
Sell
$21.34
16,389
$350K
0
NASDAQ COLL Collegium Pharmaceutical
SANTINI GINO / director
08/15/2025
Buy
$13.45
15,000
$202K
100,447
NASDAQ COLL Collegium Pharmaceutical
SANTINI GINO / director
08/15/2025
Sell
$37.19
5,405
$201K
95,042
NASDAQ COLL Collegium Pharmaceutical
SANTINI GINO / director
08/15/2025
Sell
$13.45
15,000
$202K
0
NASDAQ COLL Collegium Pharmaceutical
Dreyer Scott / officer: EVP & Chief Commercial Officer
08/13/2025
Buy
$21.34
4,861
$104K
108,474
NASDAQ COLL Collegium Pharmaceutical
Dreyer Scott / officer: EVP & Chief Commercial Officer
08/13/2025
Sell
$38.03
4,861
$185K
103,613
NASDAQ COLL Collegium Pharmaceutical
Dreyer Scott / officer: EVP & Chief Commercial Officer
08/13/2025
Sell
$21.34
4,861
$104K
16,389
NASDAQ COLL Collegium Pharmaceutical
Rubric Capital Management LP / 10 percent owner
08/13/2025
Sell
$37.85
25,000
$946K
3.13M
NASDAQ COLL Collegium Pharmaceutical
Freund John Gordon / director
08/08/2025
Sell
$34.36
11,659
$401K
23,129

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous